REXAHN PHARMACEUTICALS INC - COM (RNN)

CUSIP: 761640101

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
8,822,185
Share change
-15,447
Total reported value
$3,203,000
Price per share
$0.36
Number of holders
27
Value change
-$119,708
Number of buys
8
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REXAHN PHARMACEUTICALS INC - COM (RNN) as of Q4 2015

As of 31 Dec 2015, REXAHN PHARMACEUTICALS INC - COM (RNN) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,822,185 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, HUDSON VALLEY INVESTMENT ADVISORS INC /ADV, Northeast Financial Consultants Inc, Bank of New York Mellon Corp, KCG Holdings, Inc., and Benin Management CORP. This page lists 27 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.